Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
When the Drummond Brothers first launched MedPal AI (MPAL) onto the AIM Market, I was highly sceptical about its valuation and prospects. Initially MedPal performed strongly reaching a high of 13.5 pence on 4 September 2025 on initial enthusiasm for AI linked plays. Reality in the form of reported and a number of fund raises resulted in its share price dropping below IPO price to as low as 2.225 pence per share in May 2026. The price has since risen to a mid price of 3.50 pence. So my bear call into the huff and puff generated by evil PR genius Councillor Bick has been vindicated. But…
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.